ClearPoint Neuro, Inc.
CLPT
$10.64
$0.141.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.60% | 9.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.60% | 9.19% | |||
| Cost of Revenue | 9.13% | 11.43% | |||
| Gross Profit | 8.26% | 7.77% | |||
| SG&A Expenses | -6.43% | 12.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.69% | 9.52% | |||
| Operating Income | 7.84% | -9.98% | |||
| Income Before Tax | 3.26% | -11.55% | |||
| Income Tax Expenses | 38.89% | -- | |||
| Earnings from Continuing Operations | 3.14% | -11.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.14% | -11.88% | |||
| EBIT | 7.84% | -9.98% | |||
| EBITDA | 12.81% | -12.98% | |||
| EPS Basic | 4.97% | -11.37% | |||
| Normalized Basic EPS | 5.17% | -11.07% | |||
| EPS Diluted | 4.97% | -11.37% | |||
| Normalized Diluted EPS | 5.17% | -11.07% | |||
| Average Basic Shares Outstanding | 1.95% | 0.47% | |||
| Average Diluted Shares Outstanding | 1.95% | 0.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||